136 related articles for article (PubMed ID: 31498858)
1. Is it possible to eliminate hepatitis C from the prisons of Catalonia, Spain, in 2021?
Marco A; Guerrero RA; Turu E; Gallego C; Teixidó N; Sastre A; Caylà JA;
Rev Esp Sanid Penit; 2019; 21(1):38-41. PubMed ID: 31498858
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
[TBL] [Abstract][Full Text] [Related]
3. Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002-2016.
Marco A; Guerrero RA; Vergara M; Gallego C; Solé C; Planella R; Vaz ME; Teixidó N; Sastre A; Touzón C; da Silva A; Almada G; Ruíz A; Caylà JA; Turu E
Int J Drug Policy; 2019 Oct; 72():189-194. PubMed ID: 31160156
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
[TBL] [Abstract][Full Text] [Related]
5. Scale-up of hepatitis C treatment in prisons is key to national elimination.
Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
[No Abstract] [Full Text] [Related]
6. Elimination of hepatitis C virus in a prison: An 18-year experience.
Nogales-Garcia M; Parraza Diez N; Vargas Axpe A; Velasco Garcia R; Larrabeiti-Etxebarria A; Roy Lopez-Cano I; Atrio Alvarez I; Lopez de Arcaute Trincado A; Fernandez Lopez de Vicuña EM; Saez de Adana Arroniz E; Martínez Martínez C; Portu Zapirain J
Enferm Infecc Microbiol Clin (Engl Ed); 2024 May; 42(5):236-241. PubMed ID: 37117143
[TBL] [Abstract][Full Text] [Related]
7. Eradicating hepatitis C from the New South Wales prison system.
Blogg J; Wood J; McGrath C; Lobo C
Med J Aust; 2018 Apr; 208(6):276. PubMed ID: 29614945
[No Abstract] [Full Text] [Related]
8. [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting].
Saiz de la Hoya-Zamácola P; Marco-Mouriño A; Clemente-Ricote G; Portilla-Sogorb J; Boix-Martínez V; Núñez-Martínez O; Reus-Bañuls S; Teixidó i Pérez N
Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):568-75. PubMed ID: 17125677
[TBL] [Abstract][Full Text] [Related]
9. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
Cuadrado A; Llerena S; Cobo C; Pallás JR; Mateo M; Cabezas J; Fortea JI; Alvarez S; Pellón R; Crespo J; Echevarría S; Ayesa R; Setién E; Lopez-Hoyos M; Crespo-Facorro B; Agüero J; Chueca N; Garcia F; Calleja JL; Crespo J
Am J Gastroenterol; 2018 Nov; 113(11):1639-1648. PubMed ID: 29946175
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons.
Lim AG; Stone J; Hajarizadeh B; Byrne M; Chambers GM; Martin NK; Grebely J; Dore GJ; Lloyd AR; Vickerman P
Hepatology; 2021 Nov; 74(5):2366-2379. PubMed ID: 34105797
[TBL] [Abstract][Full Text] [Related]
11. Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study.
Marco A; Antón JJ; Trujols J; Saíz de la Hoya P; de Juan J; Faraco I; Caylà JA;
BMC Infect Dis; 2015 Aug; 15():355. PubMed ID: 26286450
[TBL] [Abstract][Full Text] [Related]
12. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
13. The contribution of telemedicine to hepatitis C elimination in a correctional facility.
Jiménez Galán G; Alia Alia C; Vegue González M; García Berriguete RMª; Fernández González F; Fernández Rodríguez CM; González Fernández M; Gutiérrez García ML; Losa JE; Velasco M; Moreno L; Hervás R; Delgado-Iribarren A; Palacios García-Cervigón G
Rev Esp Enferm Dig; 2019 Jul; 111(7):550-555. PubMed ID: 31215210
[TBL] [Abstract][Full Text] [Related]
14. Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.
van Dijk M; Kracht PAM; Arends JE; Blokzijl H; Burger DM; van Erpecum KJ; van Hoek B; de Knegt RJ; Posthouwer D; Ramsoekh D; Rijnders BJA; Schinkel J; Willemse SB; van der Valk M; Drenth JPH; Behalf Of The HepNed Study Group O
Neth J Med; 2019 May; 77(4):131-138. PubMed ID: 31502544
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C and HIV in Spanish prisons].
Soriano V; González-Lahoz J
Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):51-2. PubMed ID: 15743572
[No Abstract] [Full Text] [Related]
16. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C.
Marco A; Esteban JI; Solé C; da Silva A; Ortiz J; Roget M; Sarriera C; Teixidó N; Guerrero RA; Caylà JA
J Hepatol; 2013 Jul; 59(1):45-51. PubMed ID: 23523577
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effectiveness and discontinuation of interferon-free therapy for hepatitis C in prison inmates and noninmates.
Marco A; Roget M; Cervantes M; Forné M; Planella R; Miquel M; Ortiz J; Navarro M; Gallego C; Vergara M;
J Viral Hepat; 2018 Nov; 25(11):1280-1286. PubMed ID: 29851225
[TBL] [Abstract][Full Text] [Related]
19. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
[TBL] [Abstract][Full Text] [Related]
20. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
